Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study
CONCLUSIONS: After five years of follow-up, EBRT alone or combined with HDR-BT boost had a similar impact on HRQL in patients with high-risk localized PCa. However, patients in the EBRT alone group experienced greater worsening of hormonal domain according to EPIC questionnaire.PMID:34025730 | PMC:PMC8117716 | DOI:10.5114/jcb.2021.103580
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Authors: Evelyn Mart ínez Olatz Garin Yolanda Pardo Pablo Fern ández Benjamin Guix Cristina Guti érrez Ana Boladeras Ferran Ferrer Tania Hern ández Adriana Ayala Mikel Egiguren Gema Fern ández V íctor Muñoz V íctor Macías Joan Pera Àngels Pont Montserrat Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Hormones | Incontinence | Maca | Prostate Cancer | Radiation Therapy | Study